Connecting you to content on EBSCOhost

Works by Chatterjee, Essha

Results: 4

1

Anticancer activity of RM-3-22: a TAZQ-based hydroxamic acid derivative targeting NSCLC in vitro and in vivo.

Published in:

Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1544666

By:

Chatterjee, Essha;
Sharma, Ram;
Dey, Biswajit;
Singh, Hoshiyar;
Naik, Aliva;
Khan, Anjesh;
Basak, Santanu;
Bansode, Ankush;
Sachdeva, Ritika;
Sharma, Anamika;
Kumar, Rahul;
Naik, Pradeep;
Singh, Pankaj Kumar;
Nepali, Kunal;
Guru, Santosh Kumar

Publication type:

Article

2

Induction of apoptosis in human bladder cancer cells by triterpenoids isolated from Holarrhena antidysenterica through differential reactive oxygen species generation.

Published in:

Natural Product Research, 2021, v. 35, n. 24, p. 5629, doi. 10.1080/14786419.2020.1819272

By:

Ghosh, Anindita;
Roy, Rituparna;
Chatterjee, Essha;
Bankura, Biswabandhu;
Guru, Santosh;
Panda, Chinmay Kumar

Publication type:

Article

3

LCMS-DNP based dereplication of Araucaria cunninghamii Mudie gum-resin: identification of new cytotoxic labdane diterpene.

Published in:

Natural Product Research, 2022, v. 36, n. 24, p. 6207, doi. 10.1080/14786419.2021.2024530

By:

Sahu, Bharat;
Bhardwaj, Nivedita;
Chatterjee, Essha;
Dey, Biswajit;
Tripathi, Nancy;
Goel, Bharat;
Kushwaha, Manoj;
Kumar, Brijesh;
Singh, Bikarma;
Guru, Santosh Kumar;
Jain, Shreyans K.

Publication type:

Article

4

High nuclear expression of HIF1α, synergizing with inactivation of LIMD1 and VHL, portray worst prognosis among the bladder cancer patients: association with arsenic prevalence.

Published in:

Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 8, p. 2309, doi. 10.1007/s00432-021-03661-z

By:

Basu, Mukta;
Chatterjee, Amvrin;
Chakraborty, Balarko;
Chatterjee, Essha;
Ghosh, Sabnam;
Samadder, Sudip;
Pal, Dilip Kumar;
Roy, Anup;
Chakrabarti, Jayanta;
Ghosh, Amlan;
Panda, Chinmay Kumar

Publication type:

Article